XML 49 R31.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS’ EQUITY (Tables)
 12 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of weighted-average assumptions used to estimate the fair values of the stock options granted
     
   Lunai Bioworks Inc.
Expected term (in years)   5.5  
Volatility   109.45% – 118.99%
Risk free interest rate   3.86%- 4.40%
Dividend yield   0%
Schedule of stock options outstanding
                                   
   Options Outstanding     Options Exercisable
   Exercise Price Ranges  Number Outstanding  Weighted Average Remaining Contractual Life (years)  Weighted Average Exercise Price  Number Exercisable  Weighted Average Remaining Contractual Life (years)  Weighted Average Exercise Price
  $0.45–4.50    4,623,614    8.97   $0.75    

567,233

    8.71   $0.96 
  $4.51–6.50    —    —   $—    —    —   $— 
  $6.51–12.00    —    —   $—    —    —   $— 
Total      4,623,614    8.97   $0.75    

567,233

    8.71   $0.96 
Schedule of Stock option activity
                    
   Shares  Weighted Average Exercise
Price		  Average Remaining Life  Weighted Average Intrinsic
Value
             
Outstanding at June 30, 2024   5,527,852   $2.11    7.30   $— 
Granted   4,249,665   $0.64           
Exercised   —   $—           
Forfeited   —   $—           
Expired/Canceled    (5,153,903)  $2.12           
Outstanding at June 30, 2025   4,623,614   $0.75    8.97   $— 
Exercisable at June 30, 2025   567,233   $0.96    8.71   $— 
Schedule of common stock purchase warrants outstanding
                     
   Warrants Outstanding  Warrants Exercisable
         Weighted        Weighted   
         Average  Weighted     Average  Weighted
         Remaining  Average     Remaining  Average
   Exercise  Number  Contractual  Exercise  Number  Contractual  Exercise
   Price  Outstanding  Life (years)  Price  Exercisable  Life (years)  Price
   $0.53    471,698    2.99         471,698    2.99     
   $0.65    741,274    3.09         741,274    3.09     
   $1.14    1,189,036    2.73         1,189,036    2.73     
   $1.47    642,128    3.96         642,128    3.96     
   $1.48    50,740    3.99         50,740    3.99     
   $0.50-1.68         3,175,00    0.65    3,175,000    0.65     
                                    
Total        6,269,876   1.88   $0.91    6,269,876   1.88   $

0.91

 
Schedule of warrants outstanding
               
    Shares  Weighted Average Exercise
Price		  Weighted Average Remaining
Life
          
Outstanding at June 30, 2024   3,094,876   $1.00    3.48 
Granted   3,175,000   $0.82    0.65 
Exercised   —   $—    — 
Cancelled/Expired   —   $—    — 
Outstanding and exercisable at June 30, 2025   6,269,876   $0.91    1.88